Clene (CLNN) News Today → Secret energy grid to power millions of homes (From Porter & Company) (Ad) Free CLNN Stock Alerts $0.37 +0.02 (+5.69%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29, 2024 | americanbankingnews.comClene (NASDAQ:CLNN) Stock Rating Reaffirmed by HC WainwrightMay 28, 2024 | globenewswire.comClene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)May 24, 2024 | theglobeandmail.comClene (NASDAQ: CLNN) Looking to Transform Healthcare for Individuals with Neurodegenerative DiseasesMay 23, 2024 | markets.businessinsider.comAnalyst Scoreboard: 6 Ratings For CleneMay 14, 2024 | finance.yahoo.comClene to Present at Upcoming May ConferencesMay 14, 2024 | globenewswire.comClene to Present at Upcoming May ConferencesMay 10, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Regulus (RGLS), Zevra Therapeutics (ZVRA)May 10, 2024 | marketbeat.comFY2028 EPS Estimates for Clene Inc. (NASDAQ:CLNN) Boosted by AnalystClene Inc. (NASDAQ:CLNN - Free Report) - Equities research analysts at Roth Capital raised their FY2028 earnings per share estimates for Clene in a report released on Wednesday, May 8th. Roth Capital analyst J. Aschoff now anticipates that the company will earn $0.91 per share for the year, up frMay 10, 2024 | theglobeandmail.comClene (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation HighlightsMay 9, 2024 | finance.yahoo.comClene First Quarter 2024 Earnings: Misses ExpectationsMay 8, 2024 | finanznachrichten.deClene Inc.: Clene Reports First Quarter 2024 Financial Results and Recent Operating HighlightsMay 8, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Clene (CLNN)May 8, 2024 | investorplace.comCLNN Stock Earnings: Clene Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | globenewswire.comClene Reports First Quarter 2024 Financial Results and Recent Operating HighlightsMay 1, 2024 | finance.yahoo.comIBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob EtheringtonApril 23, 2024 | finance.yahoo.comBullish Clene Insiders Loaded Up On US$9.58m Of StockApril 17, 2024 | benzinga.comThe Analyst Verdict: Clene In The Eyes Of 5 ExpertsApril 16, 2024 | msn.comClene stock rallies 52% post-market on MS drug dataApril 16, 2024 | globenewswire.comEvidence for Clene's CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual MeetingMarch 28, 2024 | marketbeat.comClene Inc. (NASDAQ:CLNN) Short Interest Down 38.5% in MarchClene Inc. (NASDAQ:CLNN - Get Free Report) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 262,500 shares, a drop of 38.5% from the February 29th total of 427,100 shares. Based on an average daily volume of 1,090,000 shares, the short-interest ratio is currently 0.2 days.March 27, 2024 | theglobeandmail.comClene (NASDAQ: CLNN) Announces Operational Highlights for Lead Therapeutic Candidate for ALS and MSMarch 26, 2024 | investorplace.com3 Penny Stocks That Could Be Multibaggers in the Making: March EditionMarch 20, 2024 | marketbeat.comClene's (CLNN) "Buy" Rating Reaffirmed at BenchmarkBenchmark restated a "buy" rating and issued a $5.00 target price on shares of Clene in a report on Wednesday.March 19, 2024 | finance.yahoo.comIBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob EtheringtonMarch 17, 2024 | morningstar.comClene Inc Ordinary SharesMarch 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Clene Amid Positive ALS Drug Data and Market DynamicsMarch 15, 2024 | marketbeat.comHC Wainwright Weighs in on Clene Inc.'s FY2028 Earnings (NASDAQ:CLNN)Clene Inc. (NASDAQ:CLNN - Free Report) - Equities research analysts at HC Wainwright lifted their FY2028 earnings estimates for shares of Clene in a report released on Wednesday, March 13th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of $0.53March 15, 2024 | globenewswire.comClene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®March 14, 2024 | marketbeat.comClene Inc. (NASDAQ:CLNN) Short Interest UpdateClene Inc. (NASDAQ:CLNN - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 29th, there was short interest totalling 427,100 shares, a growth of 86.8% from the February 14th total of 228,700 shares. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is currently 0.4 days.March 13, 2024 | finanznachrichten.deClene Inc.: Clene Reports Full Year 2023 Financial Results and Recent Operating HighlightsMarch 13, 2024 | markets.businessinsider.comBreaking Down Clene: 4 Analysts Share Their ViewsMarch 13, 2024 | benzinga.comClene: Q4 Earnings InsightsMarch 13, 2024 | globenewswire.comClene Reports Full Year 2023 Financial Results and Recent Operating HighlightsMarch 7, 2024 | finance.yahoo.comClene to Present at the 36th Annual ROTH ConferenceFebruary 29, 2024 | markets.businessinsider.comBuy Rating Affirmed for Clene’s CNM-Au8 on Promising Long-Term Clinical OutcomesFebruary 29, 2024 | globenewswire.comClene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024February 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for Clene Amidst Strong Clinical Data and Financial StabilityFebruary 22, 2024 | markets.businessinsider.comClene Reports Significant Survival Benefit With CNM-Au8® Treatment in ALS EAP Compassionate Use ProgramsFebruary 17, 2024 | finance.yahoo.comCLNN Mar 2024 1.000 putFebruary 17, 2024 | finance.yahoo.comCLNN Mar 2024 3.000 callFebruary 8, 2024 | theglobeandmail.comClene (NASDAQ: CLNN) CEO Discusses MS Trial Results During Latest Proactive InterviewFebruary 6, 2024 | finance.yahoo.comIbogaine By David Dardashti Offers Free Online Support for Post-Treatment CareFebruary 6, 2024 | theglobeandmail.comClene (NASDAQ: CLNN) Reports Statistically Significant Long-Term Improvements for VISIONARY-MS ParticipantsFebruary 6, 2024 | marketbeat.comClene Inc. (NASDAQ:CLNN) Shares Sold by Vivo Capital LLCVivo Capital LLC reduced its stake in Clene Inc. (NASDAQ:CLNN - Free Report) by 41.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,645,338 shares of the company's stock after sellJanuary 24, 2024 | finance.yahoo.comClene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS TreatmentJanuary 23, 2024 | theglobeandmail.comClene (NASDAQ: CLNN) VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS TreatmentJanuary 11, 2024 | proactiveinvestors.comClene Inc. announces positive results from CNM-Au8 results from MS trialJanuary 10, 2024 | finance.yahoo.comClene Announces Significant Positive Results from LTE VISIONARY-MS TrialJanuary 9, 2024 | markets.businessinsider.comBuy Rating Affirmed: Clene’s CNM-Au8 Shows Promising Efficacy in MS Treatment StudyJanuary 8, 2024 | markets.businessinsider.comClene Announces Improvement In Vision, Cognition With CNM-Au8 Treatment Get Clene News Delivered to You Automatically Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter. Email Address Secret energy grid to power millions of homes (Ad)This high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type of energy system the world has never seen before. Click here to get all the details. CLNN Media Mentions By Week CLNN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLNN News Sentiment▼0.000.72▲Average Medical News Sentiment CLNN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLNN Articles This Week▼02▲CLNN Articles Average Week Get Clene News Delivered to You Automatically Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATOS News Today SGMT News Today RZLT News Today ALIM News Today PRQR News Today MCRB News Today CNTX News Today RGLS News Today VERU News Today RPTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLNN) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersSecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type ...Porter & Company | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored